Medicenna Therapeutics Corp. (TSX: MDNA)

Medicenna Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is April - March.

Year Ending	Current	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	146	130	61	92	270	168
Market Cap Growth	111.36%	111.36%	-33.17%	-66.08%	60.46%	675.67%
Enterprise Value	129	108	25	68	237	161
Last Close Price	1.90	1.86	0.88	1.65	5.11	3.60
PE Ratio	-	-5.09	-5.67	-3.97	-14.68	-13.87
PB Ratio	25.49	24.95	2.08	4.40	7.09	4.66
P/FCF Ratio	-7.97	-7.97	-4.84	-3.89	-17.66	-31.11
P/OCF Ratio	-7.97	-7.97	-4.84	-3.89	-17.66	-31.11
EV/EBITDA Ratio	-5.77	-5.77	-1.54	-3.04	-13.66	-19.61
EV/EBIT Ratio	-5.77	-5.77	-1.54	-3.04	-13.63	-19.59
EV/FCF Ratio	-6.63	-6.63	-1.99	-2.90	-15.49	-29.82
Debt / Equity Ratio	-	-	-	-	0.00	0.00
Debt / FCF Ratio	-	-	-	-	0.00	-0.01
Quick Ratio	1.30	1.30	4.95	8.33	9.93	20.80
Current Ratio	1.37	1.37	5.23	8.92	10.26	20.86
Return on Equity (ROE)	-146.88%	-146.88%	-39.94%	-76.56%	-46.54%	-42.70%
Return on Assets (ROA)	-42.00%	-42.00%	-34.02%	-42.75%	-27.10%	-23.87%
Return on Capital (ROIC)	-67.31%	-67.31%	-40.50%	-47.60%	-29.23%	-26.54%
Earnings Yield	-19.25%	-19.66%	-16.40%	-24.62%	-6.40%	-4.91%
FCF Yield	-12.55%	-12.55%	-20.65%	-25.72%	-5.66%	-3.21%
Buyback Yield / Dilution	-7.57%	-7.57%	-19.25%	-9.31%	-55.68%	-24.25%
Total Shareholder Return	-7.57%	-7.57%	-19.25%	-9.31%	-55.68%	-24.25%

Source: S&P Capital IQ. Standard template.